Molina Healthcare, Inc.
MOH
Category
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 1.31K | 6,899.13% |
| 2025 | 18.68 | 31.80% |
| 2024 | 14.17 | -26.36% |
| 2023 | 19.24 | -20.16% |
| 2022 | 24.10 | -13.62% |
| 2021 | 27.90 | 49.63% |
| 2020 | 18.65 | 62.82% |
| 2019 | 11.45 | 4.55% |
| 2018 | 10.95 | -230.61% |
| 2017 | -8.39 | -102.25% |
| 2016 | 373.04 | 1,606.06% |
| 2015 | 21.87 | -45.92% |
| 2014 | 40.43 | 33.88% |
| 2013 | 30.20 | -76.44% |
| 2012 | 128.20 | 161.20% |
| 2011 | 49.08 | 252.91% |
| 2010 | 13.91 | -27.76% |
| 2009 | 19.25 | 145.62% |
| 2008 | 7.84 | -58.22% |
| 2007 | 18.76 | -5.65% |
| 2006 | 19.88 | -25.68% |
| 2005 | 26.75 | 19.30% |
| 2004 | 22.42 | 70.03% |
| 2003 | 13.19 | 0.58% |
| 2002 | 13.11 | -1.24% |
| 2001 | 13.28 | -50.33% |
| 2000 | 26.73 | 0.00% |
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 22.58 | -98.27% |
US
|
|
| 23.60 | -98.19% |
US
|
|
| 19.03 | -98.54% |
US
|
|
| 11.94 | -99.09% |
US
|
|
| 40.15 | -96.93% |
US
|
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.